On the other hand, COX-2 inhibitors, such as the antifungal ketoconazol, decreased COX-2 expression, resulting in Parkin mitochondrial translocation and excessive mitophagy activation in a preclinical model of HCC, together contributing to HCC cell apoptosis and tumor suppression [160]. Here, PRKN is linked to hepatocellular carcinoma.